RxDoctor Payments Data

David Haynes, MD

Otology & Neurotology · Nashville, TNNPI 1710086145

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Med-el Corporation at 53.7% of the total. Reporting peaked in 2022 at $16,947 and has fallen 86.3% since, to $2,325 in 2025.

$43,704in general payments, 2019–2025

Across 71 payments — averaging $615.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Med-el Corporation$23K
  • Medical Device Business Services, Inc.$14K
  • Medtronic$2K
  • Cochlear Ltd$2K
  • Cochlear Americas$1K
  • Advanced Bionics, LLC$700
  • plus $326 from 3 others
$31,977in research payments, 2019–2025

Across 21 payments — averaging $1522.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Med-el Corporation$19K
  • Advanced Bionics, LLC$13K

What the payments were for

  • Consulting fees$14,76634%
  • Speaking & faculty fees$3,0007%
  • Travel & lodging$20,35047%
  • Food & beverage$5,58713%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Tennesseeto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$54,690
Medicare patients
248
Services billed
424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth18$3,785
Mometasone Furoate25$569
Azelastine Hcl24$558
Glycopyrrolate23$422
Methylprednisolone11$25

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →